Eighth Affiliated Hospital, Sun Yat-sen University
Phase
Not applicable
Started
2024-10-23
Last updated
2025-06-26
Condition(s) studied
StrokeGait TrainingGait Disorders
Investigational drug(s) / intervention(s)
Robot-assisted overground gait training
Robot-assisted overground gait training: Post-stroke patients were required to complete a session of robot-assisted training, which involved nine repetitions of 5-meter overground walking (three trials for each of the three controllers).
Study summary
Post-stroke patients were required to complete a session of robot-assisted training, which involved nine repetitions of 5-meter overground walking (three trials for each of the three controllers) in a rectangular hospital corridor.
Eligibility
Sex
ALL
Min age
18 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria:
Stroke patients aged between 18 and 75 years. Patients who are medically stable and able to stand and walk independently for at least 10 meters during rehabilitation.
Stroke event occurred at least 3 months ago Patients with impaired lower limb motor function but with some degree of muscle activity in the lower extremities.
Patients without severe cognitive impairment and capable of understanding and following the treatment protocol.
Patients without severe balance or coordination disorders, able to maintain balance and perform gait training with assistive devices.
Patients without lower limb fractures or other serious skeletal issues affecting the lower limbs.
Patients without severe cardiovascular or other serious illnesses and able to tolerate the intensity and duration of rehabilitation therapy.
Patients willing to participate in the study and able to provide written informed consent.
Exclusion Criteria:
Severe cognitive impairment that prevents the patient from understanding or complying with the treatment protocol.
Severe balance or coordination disorders that prevent the patient from maintaining balance and participating in gait training, even with assistive devices.
Other serious motor disorders, such as abnormal muscle tone or ataxia, which may interfere with the effectiveness of rehabilitation therapy.
Active cardiovascular disease or other serious systemic illnesses that may affect the patient's safety or treatment outcomes.
Lower limb fractures or other serious skeletal issues that may impact the suitability and safety of robot-assisted rehabilitation therapy.
Patients currently receiving other rehabilitation or experimental treatments. Patients with skin ulcers, infections, or other severe skin conditions that may interfere with the use and application of robotic devices.
Unexplained discomfort or pain symptoms that may limit the patient's ability to participate in rehabilitation therapy.
Failure to meet other specific inclusion criteria outlined in the study protocol.
Primary outcome measure(s)
Change in 10 Meter Walk Test from baseline gait speed — Baseline, immediately after intervention Gait speed will be assessed by instructing participants to walk at their maximum safe speed. Each participant will start 1 meter before the designated start line and continue walking until 1 meter past the finish line. The time taken to traverse the measured distance will be recorded using a stopwatch to the nearest one hundredth of a second.
Trial sites (1)
Facility
City
Region
Status
Eight affiliated hospital, Sun Yat-Sen University
Shenzhen
Guangzhou
Recruiting
More Eighth Affiliated Hospital, Sun Yat-sen University trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.